pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-682 |
Genomic Coordinates | chr13: 75645046 - 75645141 |
Synonyms | Mirn682, mir-682, mmu-mir-682, Mir682 |
Description | Mus musculus miR-682 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-682 |
Sequence | 74| CUGCAGUCACAGUGAAGUCUG |94 |
Evidence | Experimental |
Experiments | MPSS |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Edil3 | ||||||||||||||||||||
Synonyms | Del-1, Del1 | ||||||||||||||||||||
Description | EGF-like repeats and discoidin I-like domains 3 | ||||||||||||||||||||
Transcript | NM_001037987 | ||||||||||||||||||||
Other Transcripts | NM_010103 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Edil3 | |||||||||||||||||||||
3'UTR of Edil3 (miRNA target sites are highlighted) |
>Edil3|NM_001037987|3'UTR 1 AGTGCGGGGCCGCACATCCCACAATGCTTTTCTTTATTTTCCTATAAGTATCTCCACGAAATGAACTGTGTGAAGCTGAT 81 GGAAACTGCATTTGTTTTTTTCAAAGTGTTCAAATTATGGTAGGCTACTGACTGTCTTTTTAGGAGTTCTAAGCTTGCCT 161 TTTTAATAATTTAATTTGGTTTCCTTTGCTCAACTCTCTTATGTAATATCACACTGTCTGTGAGTTACTCTTCTTGTTCT 241 CTGAATTCTATAGATTGGTTGAAGTATAGTAGGCAAAGCAAGTCTTCTTTTTACAGCAAAACTTAAAAACAATCTCACAG 321 TCATCAGATGGAAGGGTTAAGGGAGAACTTTGGTCACTATTCAATTAACTCTTATAAAATGTTACAATGTTAGCAATACA 401 GTTTTTTGTTATGAATTTGATCATCTTGATTGTTTCCCTGTGTCTAATGCTGTTAGTATGTATTACAGAGACTTGGTGAA 481 AATTATTTGATATGCAGGACCATTAATATGACAATTCTAGTTTTATTTTTTTCACTTACAATAAAATACTAAGTTCTTTA 561 TGTTTAATTTTATATTATTTATATGCTACATAAACAGGCCAATATTCTTTGTCATTGCATTTTCTCCCTTTATTTACCTT 641 AAAGTCCTGTTTTTATTTATAGACACAGAACATATATTAATATACGTTGAACATGATTGGATATCAGTAAATGCTTCTAT 721 ATTAAACATTAATACATTGAATCTGAATTTTCATTTTTGAAGAAAGCTATATGCATTTCATTTCCAAAGGCTATCTGAGA 801 TTCCCTTGTTACAGTTTAGTGAAAAAGAACAGAAAAACACTATGGCCCTTGAATTTAAATCTTCATTTCTTTGAGATAAC 881 AGAATCACTATCTGTGTGTTTAATACACTAGCAAATGTATGTGAGCCTACTGCTGCACAGCTGGGCTAAGTGCACTCAAC 961 AATTCTTTGCAAATTTCCACATTTCCTGTGAAATGAAAATTCCAATGCTGTTTAAAACCAGTGGTAGTTTCTGAAGAAAG 1041 CACATTGTAAAATTATTTGTGAGAAGCGACGTATTTACAAATGACAAAGTCATAAAACATCTTCAGGATGAAAATTGATT 1121 TTTATTTCTTTTGCTTCAAAGGTCTTAGAAAAACTAAGCAATTATCATAACAGTTTGTTATTGATAATGGAGGCATCATT 1201 GACATATGTCTCAAATTAAAGCTCACACTGCCTCCATAAATGTCCTACATACCTAATTTATAAGCTTAACACATATTTAT 1281 TTTATAAGGCTTTGACACAGAATTATTGGAGTTTTAAATTGAAGATCCAGGAAAGGAAAGGGTGGATGTGGATGAAATGC 1361 TAAAGAACTACACAACACTGCTATATTTTATTTTATTTTTGTCTTTAATATGTGTGCTGTATAAGCAAAGCCACTACTGT 1441 TATGTCCTGTCTGTTCACGTGTTCACAGCATCTCTCAATGATGTAAATATGAAGCAGTCTTCAATCACAGTGAAGAATTG 1521 AAAGTGAAAGTCAATCACATTACTGTTTTAAATGACAGCAAATTCATTGTTCTATGGTAACTGTCAGGCCAAATGTTTCT 1601 CCTTGCCCACCTGCTTACTGCAACAGATTTGTTAAAAATCTGTTGATTTTCAGCATATAAAATGCTGAATAATTTTTAAC 1681 ATTTTCCCAAAAGAAAACTGATATGCCCTCAATATTATTGTCCTAGAAAATGTTTTAAATTATTAATATAGAATATTTAA 1761 AATAGTATTTTTAATTAAAATAGTTATACATAGAATCACTTATGCCCTAAAGGTACATTTTCTGTCTTGCCATGGTCCTT 1841 GTTTCTATCAGTGATAACCATACTACTGAATTTGTAGCTGTTTTTCCTTGCAGATTCTTTATCCTTAATATAAAATTCCA 1921 GAAATTATGAATAATACGCTGTGCTGAAATACTTTTCAAAACTGTTCTTGATTTCATGTGGCACTGCTGGTACATGTTTA 2001 AAATTTGTTCTCCAAAGGAGTTGTTAGTAATGGTATCTGCTACTATTTACAAGGCTGGTGAGAGGCTTTCTCTTGCTTGT 2081 CCTCTTCCTCTCAGCTTCATGCGCTACCTACAGCATAGCTTACGCAATGGATATGCGTTTGTCCACAAGGGTGCTTGCAC 2161 AAAAATTAATGACATGTATTAGGGAGTAGCTTGTATCAGTGGCTTCAAGTCGAAACATGGAATTTTCATTTAGTTTTATT 2241 TGCAAGTAAAATTTTACAAACACACAACCTGGAATTCCCTACTCTTCACTATACTACATAATTATTATGAGATAATTTCA 2321 TTGTATAGAAGATTATGAATTAATTAGCTTTAAAAATATCAATTTCATGTATTTTATTCTAATCATTTGTCACAGACACT 2401 AATTCCAACTTTAGGGTTGACTTTCTCTCTGTGAATGTCTTCAGAAAGATAAGAATGGATCTTGAAGACCAGGCATTAAT 2481 GACTATATCTTTGCTAGACATCAAATTATGAAATATAACATTGAATGTTGTAGTCTGGTGTGTCTGTAAGGACAGAAATA 2561 ACTAAGATACACATAACTTTTGCAAACTTTCAAGCTGTGTAATATTCCAATGTTGTTGTTTTTTTTTTTGTAGATATACT 2641 TAAATCATGTAGGATGTTGTAAACTCAGTATGATCCTGTCTAGTCTTCAAACTTAAAATAAACTTTTGAAAAACTGTGCT 2721 ACTTTTGAAGTTGTGTTTTAAACATCTGTGTAAGAATGTACAAATTGTCTGTGGCTGCCCTTAACCTTCAACATATGATT 2801 AGCTTAATTTGTATTTATATAGATTAACTAAATGCACAAAGAAAAAGAGATTATAATTGTATAATTATTTTAAAATATAA 2881 GACTGCAAAAGTGGTTTTGCCAAGATTATAAAAATGTATAAATTTATCCATACCTTTTTATTTGCAGAGATTTTGCAAAA 2961 TATTAATAATCCAATTGTTTTCTCCAAATATATATTTAGAGTAGTATACTATAAGACTGATAAATCTATTATTATTCATA 3041 CAACATTTCTATTGCTTCTATTGTTCTTTCAAATTTATCATGCTCAGGAGTATATTGAAGGAAGCTGGTTGGTAATAAGC 3121 TACAATGTGACATGAATAATACATATTAGCCTCTAACTCCAGCTATTGCTTAATGAAAGTCTGAACATGTGGCTTCTTTA 3201 AGAACAGTCTTTTCTGGTTCTGTAGAAGCCACGAGTAAAAAGGGGATGTGTAACTCTAACACTTCAATATTTTCTTAGGA 3281 TTAAAAATTTAGAGTAAAACTAAAGATATTAAAAGTTGTTTTCTTCAAGCAGATCTCTGGTAGATCAAGTTTCATGGTTT 3361 TGTATACCAACATGTTCCTATCAAAGTAAATTTTAATATGAATGC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | CD4+ T cells (C57BL/6) |
Disease | MIMAT0003459 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"HITS-CLIP data was present in GSM1013594. RNA binding protein: AGO2. Condition:CD4+ T cells
"HITS-CLIP data was present in GSM1013595. RNA binding protein: AGO2. Condition:CD4+ T cells
... - Loeb GB; Khan AA; Canner D; Hiatt JB; et al., 2012, Molecular cell. |
Article |
- Loeb GB; Khan AA; Canner D; Hiatt JB; et al. - Molecular cell, 2012
MicroRNAs (miRNAs) are essential components of gene regulation, but identification of miRNA targets remains a major challenge. Most target prediction and discovery relies on perfect complementarity of the miRNA seed to the 3' untranslated region (UTR). However, it is unclear to what extent miRNAs target sites without seed matches. Here, we performed a transcriptome-wide identification of the endogenous targets of a single miRNA-miR-155-in a genetically controlled manner. We found that approximately 40% of miR-155-dependent Argonaute binding occurs at sites without perfect seed matches. The majority of these noncanonical sites feature extensive complementarity to the miRNA seed with one mismatch. These noncanonical sites confer regulation of gene expression, albeit less potently than canonical sites. Thus, noncanonical miRNA binding sites are widespread, often contain seed-like motifs, and can regulate gene expression, generating a continuum of targeting and regulation.
LinkOut: [PMID: 23142080]
|
CLIP-seq Support 1 for dataset GSM1013594 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | CD4+ T cells (C57BL/6) / CD4+ T cells, WT, biological rep8 |
Location of target site | NM_001037987 | 3UTR | AUUUUAAAAUAUAAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23142080 / GSE41285 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1013595 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | CD4+ T cells (C57BL/6) / CD4+ T cells, WT, biological rep9 |
Location of target site | NM_001037987 | 3UTR | UUUUAAAAUAUAAGA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23142080 / GSE41285 |
CLIP-seq Viewer | Link |
11 mmu-miR-682 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT584928 | Aff1 | AF4/FMR2 family, member 1 | 2 | 2 | ||||||||
MIRT589627 | Lrrc58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT591868 | Gpr146 | G protein-coupled receptor 146 | 2 | 6 | ||||||||
MIRT593404 | Stk10 | serine/threonine kinase 10 | 2 | 2 | ||||||||
MIRT594217 | Ube2k | ubiquitin-conjugating enzyme E2K | 2 | 2 | ||||||||
MIRT594471 | Edil3 | EGF-like repeats and discoidin I-like domains 3 | 2 | 2 | ||||||||
MIRT594847 | Npm3 | nucleoplasmin 3 | 2 | 2 | ||||||||
MIRT596228 | Atp6ap2 | ATPase, H+ transporting, lysosomal accessory protein 2 | 2 | 2 | ||||||||
MIRT596965 | Tmem88b | transmembrane protein 88B | 2 | 2 | ||||||||
MIRT603532 | Ptpre | protein tyrosine phosphatase, receptor type, E | 2 | 2 | ||||||||
MIRT605428 | Synrg | synergin, gamma | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|